Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 25,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: Autism Spectrum Disorder
Interventions: STRW-T, PEERS-T; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 15 Years to 21 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Carrboro, North Carolina • Cincinnati, Ohio

Conditions: Aerobic Exercise, Cognitive Change
Interventions: Moderate-intensity aerobic exercise; Behavioral
Lead sponsor: University of North Carolina, Greensboro; Other
Eligibility: 18 Years to 25 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Knee Arthropathy
Interventions: Cement, Cementless, Manual Surgery, Robotic Surgery; Procedure · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Sedation
Interventions: Dexmedetomidine load, Ketamine load, Midazolam load, Fentanyl load, Dexmedetomidine maintenance, Ketamine maintenance, Midazolam demand, Fentanyl demand, Benadryl demand; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes, Type2diabetes
Interventions: Chart Review; Other
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Leukemia
Interventions: filgrastim, oblimersen sodium, cytarabine, fludarabine phosphate; Biological · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 16 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Gastrointestinal Cancer, Gastrointestinal Neoplasms, Chemotherapy-Induced Thrombocytopenia
Interventions: Avatrombopag, Matching Placebo; Drug
Lead sponsor: Hanny Al-Samkari, MD; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Miami, Florida • Boston, Massachusetts • Portland, Oregon + 1 more

Conditions: Hidradenitis Suppurativa
Interventions: Bimekizumab, Placebo; Drug · Other
Lead sponsor: UCB Biopharma SRL; Industry
Eligibility: 18 Years and older
Enrollment: 505 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 28
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 25 more

Conditions: Metastatic Renal Cell Carcinoma
Interventions: Dovitinib, Sorafenib; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 34
States / cities: Fayetteville, Arkansas • La Jolla, California • Los Angeles, California + 26 more

Conditions: Breast Cancer, Gynecologic Cancer
Interventions: 10-15 minute, Audio-Recorded Guided Mediation Practices; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Arthritis
Interventions: PN400; Drug
Lead sponsor: POZEN; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Acetabulum Fractures
Interventions: Tranexamic Acid, Placebo; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Subjective Appetite and Satiety, Subjective Energy Levels
Interventions: Dietary Intervention; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Medication Adherence, Acute Coronary Syndrome
Interventions: PST therapy; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Presbyopia
Interventions: There is not an intervention; Diagnostic Test
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 37 Years to 48 Years
Enrollment: 45 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Head and Neck Carcinoma
Interventions: Fitbit, Questionnaire Administration, Virtual Reality Device; Device · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetic Retinopathy
Interventions: ARDA software application; Diagnostic Test
Lead sponsor: Verily Life Sciences LLC; Industry
Eligibility: 22 Years and older
Enrollment: 1,012 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 13
States / cities: Glendale, Arizona • Jonesboro, Arkansas • Montclair, California + 10 more

Conditions: Malnutrition
Interventions: Not listed
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 45 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Los Angeles, California • Pasadena, California

Conditions: Metastatic Melanoma
Interventions: vemurafenib + HD IL-2; Drug
Lead sponsor: Clinigen, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 21
States / cities: Tucson, Arizona • La Jolla, California • Miami Beach, Florida + 18 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Aging
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Glioblastoma
Interventions: Pembrolizumab, HSPPC-96, Temozolomide, Placebo, Surgery; Drug · Biological · Other + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lumbar Spine Disease, Lumbar Disc Herniation, Lumbar Spinal Stenosis
Interventions: Preoperative fluoroscopically-guided dorsal ramus block placed by the operative neurosurgeon; Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Compartment Syndrome
Interventions: Continuous tissue perfusion monitoring by near-infrared spectroscopy (NIRS) and intramuscular pressure (IMP); Other
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 60 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 7
States / cities: Denver, Colorado • Baltimore, Maryland • Minneapolis, Minnesota + 4 more

Conditions: Analgesia
Interventions: Epidural Catheter for Analgesia; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Columbia, Missouri

Search by objective public record fields.

STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade

The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults

Femoral BMD Change Following Cemented or Cementless Total Knee Arthroplasty

Alternative Sedation During Bronchoscopy

Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Avatrombopag vs. Placebo for CIT in GI Malignancies

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

Study Evaluating the Effect of Food on the Bioavailability of PN400 Components

Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid

Oat Breakfast Satiety Study

Improving Medication Adherence in Post-ACS Patients

Analysis of Defocus Curve of Pre-Presbyopic and Emerging Presbyopic Patients

A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery

ARDA Software for the Detection of mtmDR

A Nutrition-Focused QIP in Outpatient Clinics

HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Perioperative Local Anesthesia Block in Spine Surgery

Predicting Acute Compartment Syndrome (PACS)

Epidural Anesthesia /Analgesia Versus PCA for Laparoscopic Complex Ventral Hernia Repair: A Randomized Controlled Trial